Those findings suggest that EGFR inhibitors suppressed the growth of αvβ3− cancer cells while having no inhibitory effects on those αvβ3+ cancer cells, which concentrated the integrin αvβ3+ cells to induce EGFR inhibitors resistance in vitro. This evidence concerns the gene EGFR and cancer.